Osteoporosis Prevention With Low Dose Alendronate

Summary

The purpose of this study is to evaluate the efficacy of the intermittent administration of alendronate in a low dose, 70 mg once every two week, as osteoporosis prevention for menopausal, osteopenic patients, who don't want or can't receive an oestrogenic substitution treatment.

Timeline

Start

2007-09

Primary completion

2012-01

Completion

2012-01

Drugs

Indications